Outline/Topic Requirements for Term Paper
You must have your topic for your term paper approved by me by the date outlined in the syllabus. In order to have your topic approved, you must submit a fairly detailed outline of your paper (see example below) and a reference page (in APA style) listing at least half of the references you will use in your term paper. In addition, you must submit a copy of your PsycInfo search (printout of references related to your topic).
Approval of your topic will be based on two criteria: 1) appropriate topic for the course (as discussed in class) and 2) coverage of the topic that seems appropriate for the length of the paper. I will let you know if the information you have outlined seems to be too ambitious for the length of your term paper. Similarly, I will let you know if the topic you have chosen is too esoteric or specific (not enough related sources) for your term paper. In addition, I will make suggestions about the organization of your outline where appropriate.
The outline and references must be typed (a word processor is highly recommended).
Chung, J. A., & Cummings, J. L. (2000). Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease. Neurologicl Clinics, 18, 829-846.
Issa, A., M., & Keyserlinkgk, E. W. (2000). Current and future clinical trials for Alzheimer's disease: Evolving ethical concerns. Progress in Neuro Psychopharmacology and Biological Psychiatry, 24, 1229-1249.
Kukull, W. A., & Ganguli, M. (2000). Epidemiology of dementia: Concepts and overview. Neurologic Clinics, 18, 923-949.
Peterson, R. W. (2000). Aging, mild cognitive impairments and Alzheimer's disease. Neurologic Clinics, 18, 789-805.
Prasher, V. P., Barber, P. C., West, R., & Glenholmes, P. (2000). The role of magnetic resonance imaging in the diagnosis of Alzheimer disease in adults with Down Syndrome. Archives of Neurology, 53, 1310-1313.
Woods, D. C., Patterson, M. B., & Whitehouse, P. J. (2000). Utility of the Judgment Questionnaire subtest of the Neurobehavioral Cognitive Status Examination in the evaluation of individuals with Alzheimer's disease. Clinical Gerontologist, 21, 49-66.